Retrophin, Inc. RTRX was a big mover last session with shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company as the stock is now trading above the past one month's volatile price range of $17.35 to $19.81.
This pharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't remained in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Retrophin currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some other well-placed biomedical stocks worth considering are Alexion Pharmaceuticals, Inc. ALXN, Amgen Inc. AMGN and Gilead Sciences Inc. GILD. All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA ALXN: Free Stock Analysis Report
AMGEN INC AMGN: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
RETROPHIN INC RTRX: Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
